US BioTec, Inc.
USBC
$0.0001
$0.000.00%
| 03/31/2005 | |||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.10K | ||||
| Total Receivables | 529.30K | ||||
| Inventory | 186.00K | ||||
| Prepaid Expenses | -- | ||||
| Finance Division Loans and Leases Current | -- | ||||
| Total Finance Division Other Current Assets | -- | ||||
| Other Current Assets | 107.70K | ||||
| Total Current Assets | 856.00K | ||||
|
|
|||||
| Total Current Assets | 856.00K | ||||
| Net Property, Plant & Equipment | 83.50K | ||||
| Long-term Investments | -- | ||||
| Goodwill | -- | ||||
| Total Other Intangibles | -- | ||||
| Finance Div Loans & Leases LT | -- | ||||
| Total Finance Div Other LT Assets | -- | ||||
| Total Other Assets | -- | ||||
| Total Assets | 939.50K | ||||
|
|
|||||
| Total Accounts Payable | 106.10K | ||||
| Total Accrued Expenses | 11.00K | ||||
| Short-term Debt | 471.10K | ||||
| Current Portion of Long-Term Debt/Capital Leases | -- | ||||
| Finance Division Debt Current | -- | ||||
| Total Finance Division Other Current Liabilities | -- | ||||
| Total Other Current Liabilities | -- | ||||
| Total Current Liabilities | 588.20K | ||||
|
|
|||||
| Total Current Liabilities | 588.20K | ||||
| Long-Term Debt | -- | ||||
| Short-term Debt | 471.10K | ||||
| Capital Leases | -- | ||||
| Finance Division Debt Non Current | -- | ||||
| Total Finance Division Other Non Current Liabilities | -- | ||||
| Total Other Liabilities | -- | ||||
| Total Liabilities | 588.20K | ||||
|
|
|||||
| Common Stock & APIC | 270.20K | ||||
| Retained Earnings | 81.20K | ||||
| Treasury Stock & Other | -- | ||||
| Total Common Equity | 351.40K | ||||
|
|
|||||
| Preferred Stock Redeemable | -- | ||||
| Preferred Stock Non Redeemable | -- | ||||
| Preferred Stock Convertible | -- | ||||
| Preferred Stock, Others | -- | ||||
| Total Preferred Equity | -- | ||||
|
|
|||||
| Total Common Equity | 351.40K | ||||
| Total Preferred Equity | -- | ||||
| Total Minority Interest | -- | ||||
| Total Equity | 351.40K | ||||
|
|
|||||
